http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-403548-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
filingDate 1972-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1975-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-403548-A1
titleOfInvention PROCEDURE FOR OBTAINING OXIMES OF 3-FORMIL-RIFA-MICINA SV.
abstract Procedure for obtaining 3-formyl-rifamycin SV oximes of formula: **(See formula)** wherein R is selected from the group consisting of alkyl of at least 2 carbon atoms, alkenyl, alkynyl, cycloalkyl, alkoxyalkyl, cycloalkoxyalkyl, hydroxyalkyl, carboxyalkyl, carbalkoxy, carbamyl, cyanoalkyl, nitroalkyl, aryloxyalkyl, aralkoxyalkyl, heterocicloxialquilo, aminoalkyl, mono- and di-lower alkyl aminoalkyl, substituted benzyl, C2-C8 alkyl mono- and poly-aryl-substituted, lower alkyl substituted with 1 to 3 mono- or polynuclear heterocyclic rings containing at least one heteroatom selected from oxygen, nitrogen and sulfur, except morpholine rings; R1 is chosen from the group consisting of hydrogen and acetyl; and derivatives of said hydrogenated oximes at positions 16, 17, 18, 19, 28, 29; characterized in that it comprises contacting a compound selected from 3-formyl-rifamycin SV, 25-deacetyl-3-formylriphamicin SV and its hydrogenated derivatives at positions 16, 17, 18, 19, 28, 29, with an approximately equimolar amount of an O-substituted hydroxylamine of formula RONH2, wherein R is defined as above. (Machine-translation by Google Translate, not legally binding)
priorityDate 1971-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526

Total number of triples: 27.